Global Artificial Intelligence in Medicine Market Insights, Forecast to 2028

Global Artificial Intelligence in Medicine Market Insights, Forecast to 2028

Market Analysis and Insights: Global Artificial Intelligence in Medicine Market

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Artificial Intelligence in Medicine estimated at US$ 15,103.1 million in the year 2022, is projected to reach a revised size of US$ 99,638.1 million by 2028, growing at a CAGR of 36.95% during the forecast period 2022-2028.

The USA market for Artificial Intelligence in Medicine is estimated to increase from US$ 4,236.3 million in 2022 to reach US$ 30,723.7 million by 2028, at a CAGR of 33.07% during the forecast period of 2022 through 2028.

The China market for Artificial Intelligence in Medicine is estimated to increase from US$ 1,027.7 million in 2022 to reach US$ 18,664.3 million by 2028, at a CAGR of 52.32% during the forecast period of 2022 through 2028.

The Europe market for Artificial Intelligence in Medicine is estimated to increase from US$ 4,999.1 million in 2022 to reach US$ 30,659.6 million by 2028, at a CAGR of 35.29% during the forecast period of 2022 through 2028.

The global key companies of Artificial Intelligence in Medicine include IBM, NVIDIA, Microsoft, AWS, Intel Corporation, GE Healthcare, Siemens Healthineers, Medtronic, and Atomwise, etc. In 2021, the global top five players had a share approximately 26.44% in terms of revenue.

Report Includes

This report presents an overview of global market for Artificial Intelligence in Medicine market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Artificial Intelligence in Medicine, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Artificial Intelligence in Medicine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Artificial Intelligence in Medicinerevenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Artificial Intelligence in Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Artificial Intelligence in Medicine revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including IBM, NVIDIA, Microsoft, AWS, Intel Corporation, GE Healthcare, Siemens Healthineers, Medtronic, and Atomwise, etc.

By Company

NVIDIA

Intel

IBM

Google Health

Microsoft

AWS

GE Healthcare

Siemens Healthineers

Medtronic

Atomwise

Zebra Medical Vision

Cyrcadia Health

AiCure

Alibaba

BPGbio

Medasense Biometrics

Hindsait

Dell

SAP

Segment by Type

Hardware

Software

Services

Segment by Application

Auxiliary Diagnosis

Drug Discovery

Health Management

Hospital Management

Others

By Region

North America

United States

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

Southeast Asia

Rest of Asia

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Rest of Europe

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Middle East

Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Artificial Intelligence in Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Artificial Intelligence in Medicine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by Type, by Application and by country, revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, revenue for each segment.

Chapter 8: Asia Pacific by Type, by Application and by region, revenue for each segment.

Chapter 9: Latin America by Type, by Application and by country, revenue for each segment.

Chapter 10: Middle East and Africa by Type, by Application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Intelligence in Medicinerevenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions